Atlas Trials

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Clinical trial NCT02836236 · COMPLETED

Trial details

NCT number
NCT02836236
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HBVChronic HBV Infection
Start date
2015-06-19
Primary completion
2017-04-05
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.